ARTICLE | Clinical News
Serdolect sertindole regulatory update
September 22, 2008 7:00 AM UTC
FDA accepted for review an NDA from H. Lundbeck for Serdolect sertindole to treat schizophrenia. The company expects a decision in May 2009. The drug was relaunched in Europe in 2006, 8 years after EM...